▶주메뉴 바로가기

▶본문 바로가기

The Korea Herald
검색폼

THE INVESTOR
March 28, 2024

Market Now

Celltrion gains USFDA approval for Truxima

  • PUBLISHED :November 29, 2018 - 10:10
  • UPDATED :November 29, 2018 - 10:10
  • 폰트작게
  • 폰트크게
  • facebook
  • sms
  • print
[DISCLOSURE] Celltrion (068270) announced on Nov. 29 that it has obtained final sales approval from US Food and Drug Administration for its Rituximab biosimilar Truxima.

By Hwang You-mee (glamazon@heraldcorp.com)

EDITOR'S PICKS